Questo iter richiede generalmente 12-18 mesi dal momento della domanda
Fuglesang HF, Flugsrud GB, Randsborg PH, Stavem K, Utvg SE
Protein can support steadier blood sugar and combat cravings
Patients taking oral contraceptives should use non-hormonal or backup contraception for 4 weeks after starting tirzepatide and after each dose increase, as tirzepatide may reduce oral contraceptive effectiveness
It was discovered in 2012,[3] by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide.[4] Clinical trials were started in 2015, and phase 3 was completed in 2016.[5] Researchers at the University of Leeds and Novo Nordisk reported in 2017 that it can also be used for the treatment of obesity.[6] It reduces hunger, food craving and body fat.[7] FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour.[8] On December 5, 2017, semaglutide was approved by the US FDA